Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Applied BioCode Licenses its Barcoded Magnetic Bead Technology to Genetic Analysis

Published: Wednesday, January 08, 2014
Last Updated: Wednesday, January 08, 2014
Bookmark and Share
License and supply agreement for multiplex molecular diagnostic testing of microbial imbalances in the GI tract.

Applied BioCode has announced that it has signed a License and Supply Agreement for its Barcoded Magnetic Bead (BMB) technology with Genetic Analysis of Oslo, Norway.

The license from Applied BioCode will give Genetic Analysis access to specific Applied BioCode BMB patents and BioCode analyzers for Molecular Diagnostic testing of microbial imbalances in the GI tract.

The license covers both In-Vitro Diagnostic and Life Science Research applications in this area. Genetic Analysis launched their first product, the GA-map™ IBS Dysbiosis Test, at the United European Gastroenterology Week (UEGW) Meeting in Berlin, Germany in October 2013.

Genetic Analysis CEO Kari Stenersen explained that “Numerous studies have suggested the role of gut microbiota in Irritable Bowel Syndrome (IBS). However, it is only recently that links between dysbiosis (imbalance in microbiota) and IBS have been explored. Working with leading experts in Scandinavia and Europe, we initiated a series of studies in order to document the use of the GA-map™ IBS Dysbiosis Test in various IBS patient populations. We found that Dysbiosis frequency in IBS patients ranged from 35-77% between the clinics. On average, 67% of the IBS patients experienced dysbiosis. The trials have now been extended with feedback from participating investigators backing our decision to bring GA-map™ IBS Dysbiosis Test to market.” The GA-map™ IBS Dysbiosis Test can be run in any accredited molecular diagnostics laboratory.

“We are very pleased to partner with Genetic Analysis in this important and growing area of the market” said Winston Ho, President of Applied BioCode.

Ho continued, “Our Barcoded Magnetic Beads and BioCode multiplex analyzers along with Genetic Analysis’s GA-map™ IBS Dysbiosis Test will enable researchers and healthcare providers access to new ways to address this sometime debilitating disease.”

Further terms of the strategic partnership and license agreement were not immediately available.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Applied BioCode, Diatherix Ink Partnership
Applied BioCode announced that it has signed a Partnership and Supply Agreement with Diatherix Laboratories, LLC, a Eurofins company.
Friday, June 17, 2016
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!